لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Finch, DK, Midha, A, Buchanan, CL, Cochrane, D, Craggs, RI, Cruwys, S, Grahames, C, Kolbeck, R, Lowe, DC, Maltby, J, Pattison, DV, Vousden, KA, Ward, A, Sleeman, MA, Mallinder, PR, Finch, D K, Buchanan, C L, Craggs, R I, Lowe, D C, Pattison, D V

المصدر: British Journal of Pharmacology; Jan2011, Vol. 162 Issue 2, p480-490, 11p, 7 Graphs

مصطلحات موضوعية: INTERLEUKINS, ANTI-antibodies, BIOCHEMICAL mechanism of action, LYMPHOCYTES, CELL populations, CELL proliferation, INFLAMMATION, CYTOKINES, THERAPEUTIC use of monoclonal antibodies, BINDING sites, RESEARCH, ANIMAL experimentation, RESEARCH methodology, CELL receptors, MONOCLONAL antibodies, IMMUNOLOGY technique, CELL physiology, MEDICAL cooperation, EVALUATION research, COMPARATIVE studies, IMMUNITY, T cells, MICE, CHEMICAL inhibitors

المؤلفون: Cheung Eric C, Vousden Karen H, Sansom Owen, Athineos Dimitris, Ridgway Rachel, Blyth Karen, Strathdee Douglas

المصدر: BMC Proceedings, Vol 6, Iss Suppl 3, p P12 (2012)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1753-6561

URL الوصول: https://doaj.org/article/7fc1855d885843acb31b9f5b0019f4e0

المؤلفون: England E; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Rees DG; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Scott IC; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Carmen S; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Chan DTY; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Chaillan Huntington CE; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Houslay KF; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Erngren T; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Penney M; Early Oncology DMPK, Oncology R&D, AstraZeneca, Cambridge, UK., Majithiya JB; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Rapley L; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sims DA; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hollins C; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hinchy EC; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Strain MD; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Kemp BP; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Corkill DJ; Bioscience In Vivo, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., May RD; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Vousden KA; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Butler RJ; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Mustelin T; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA., Vaughan TJ; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Lowe DC; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Colley C; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., Cohen ES; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. suzanne.cohen@astrazeneca.com.

المصدر: Scientific reports [Sci Rep] 2023 Jun 17; Vol. 13 (1), pp. 9825. Date of Electronic Publication: 2023 Jun 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-1 Receptor-Like 1 Protein*/metabolism , Inflammation*/metabolism, Mice ; Humans ; Animals ; Interleukin-33/metabolism ; Cytokines/metabolism ; ErbB Receptors/metabolism ; Signal Transduction

المؤلفون: Karnell JL; Viela Bio, Gaithersburg, MD 20878, USA. jkarnell@horizontherapeutics.com., Wu Y; Viela Bio, Gaithersburg, MD 20878, USA., Mittereder N; Viela Bio, Gaithersburg, MD 20878, USA., Smith MA; Viela Bio, Gaithersburg, MD 20878, USA., Gunsior M; Viela Bio, Gaithersburg, MD 20878, USA., Yan L; Viela Bio, Gaithersburg, MD 20878, USA., Casey KA; AstraZeneca, Gaithersburg, MD 20878, USA., Henault J; AstraZeneca, Gaithersburg, MD 20878, USA., Riggs JM; AstraZeneca, Gaithersburg, MD 20878, USA., Nicholson SM; AstraZeneca, Gaithersburg, MD 20878, USA., Sanjuan MA; AstraZeneca, Gaithersburg, MD 20878, USA., Vousden KA; AstraZeneca, Cambridge CB21 6GH, UK., Werth VP; Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA., Drappa J; Viela Bio, Gaithersburg, MD 20878, USA., Illei GG; Viela Bio, Gaithersburg, MD 20878, USA., Rees WA; Viela Bio, Gaithersburg, MD 20878, USA., Ratchford JN; Viela Bio, Gaithersburg, MD 20878, USA.

مؤلفون مشاركون: VIB7734 Trial Investigators

المصدر: Science translational medicine [Sci Transl Med] 2021 May 26; Vol. 13 (595).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Interferon Type I* , Lupus Erythematosus, Cutaneous*, Autoimmunity ; Chemokines ; Dendritic Cells ; Humans

المؤلفون: Vousden KA; MedImmune Ltd, Cambridge, CB21 6GH, UK. vousdenk@medimmune.com., Lundqvist T; AstraZeneca AB R&D, Pepparedsleden 1, 431 50, Mölndal, Sweden., Popovic B; MedImmune Ltd, Cambridge, CB21 6GH, UK., Naiman B; MedImmune LLC, One MedImmune Way, Gaithersburg, MD, 20878, USA., Carruthers AM; MedImmune Ltd, Cambridge, CB21 6GH, UK., Newton P; MedImmune Ltd, Cambridge, CB21 6GH, UK., Johnson DJD; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Pomowski A; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Wilkinson T; MedImmune Ltd, Cambridge, CB21 6GH, UK., Dufner P; MedImmune Ltd, Cambridge, CB21 6GH, UK., de Mendez I; MedImmune Ltd, Cambridge, CB21 6GH, UK., Mallinder PR; MedImmune Ltd, Cambridge, CB21 6GH, UK., Murray C; AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK., Strain M; MedImmune Ltd, Cambridge, CB21 6GH, UK., Connor J; MedImmune LLC, One MedImmune Way, Gaithersburg, MD, 20878, USA., Murray LA; MedImmune Ltd, Cambridge, CB21 6GH, UK., Sleeman MA; MedImmune Ltd, Cambridge, CB21 6GH, UK., Lowe DC; MedImmune Ltd, Cambridge, CB21 6GH, UK., Huntington JA; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Vaughan TJ; MedImmune Ltd, Cambridge, CB21 6GH, UK.

المصدر: Scientific reports [Sci Rep] 2019 Feb 07; Vol. 9 (1), pp. 1605. Date of Electronic Publication: 2019 Feb 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing/*immunology , Plasminogen Activator Inhibitor 1/*immunology, Amino Acid Sequence ; Animals ; Antibodies, Neutralizing/chemistry ; Antibody Specificity ; Humans ; Mice ; Models, Molecular ; Plasminogen Activator Inhibitor 1/chemistry ; Protein Conformation ; Rats

المؤلفون: Chen B; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA Chenb@medimmune.com SimsG@MedImmune.com., Vousden KA; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Naiman B; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Turman S; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Sun H; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Wang S; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA.; Viela Bio, Gaithersburg, Maryland, USA., Vinall LMK; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Kemp BP; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Kasturiangan S; Department of Antibody Discovery and Protein Engineering, MedImmune LLC, Gaithersburg, Maryland, USA., Rees DG; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Grant E; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Hinrichs MJ; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Eck S; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., DiGiandomenico A; Microbial Sciences, MedImmune, LLC, Gaithersburg, Maryland, USA., Jack Borrok M; Department of Antibody Discovery and Protein Engineering, MedImmune LLC, Gaithersburg, Maryland, USA., Ly N; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Xiong X; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Gonzalez C; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Morehouse C; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Wang Y; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Zhou Y; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Cann J; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Zhao W; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Koelkebeck H; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Okubo K; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Mayadas TN; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Howe D; Department of Clinical Development, MedImmune Ltd, Granta Park, Great Abington, UK., Griffiths J; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Kolbeck R; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Herbst R; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Sims GP; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA Chenb@medimmune.com SimsG@MedImmune.com.

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Feb; Vol. 78 (2), pp. 228-237. Date of Electronic Publication: 2018 Nov 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Anti-Idiotypic/*pharmacology , Antigen-Antibody Complex/*drug effects , Autoimmune Diseases/*drug therapy , Immunologic Factors/*pharmacology , Receptors, IgG/*immunology, Animals ; Antibodies, Antineutrophil Cytoplasmic/immunology ; Antigen-Antibody Complex/immunology ; Autoimmune Diseases/immunology ; Dendritic Cells/immunology ; Humans ; Immunoglobulin G/immunology ; Interleukin-6/immunology ; Macaca fascicularis ; Mice ; Mice, Transgenic ; Neutrophils/immunology ; Reactive Oxygen Species/immunology ; Tumor Necrosis Factor-alpha/immunology

المؤلفون: Zhou Y; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Chen B; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Mittereder N; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Chaerkady R; Antibody Discovery and Protein Engineering, MedImmune LLC., Gaithersburg, MD, United States., Strain M; Antibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom., An LL; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Rahman S; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Ma W; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Low CP; Antibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom., Chan D; Antibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom., Neal F; Antibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom., Bingham CO 3rd; Division of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Sampson K; Division of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Darrah E; Division of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Siegel RM; Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Hasni S; Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States., Andrade F; Division of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Vousden KA; Antibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom., Mustelin T; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States., Sims GP; Department of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.

المصدر: Frontiers in immunology [Front Immunol] 2017 Sep 25; Vol. 8, pp. 1200. Date of Electronic Publication: 2017 Sep 25 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE

المؤلفون: Cohen ES; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Scott IC; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Majithiya JB; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Rapley L; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Kemp BP; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., England E; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Rees DG; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Overed-Sayer CL; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Woods J; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Bond NJ; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Veyssier CS; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Embrey KJ; Department of Discovery Sciences, Innovative Medicines, AstraZeneca, Mereside, Alderley Park, SK10 4TG, UK., Sims DA; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland 20878, USA., Snaith MR; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Vousden KA; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Strain MD; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Chan DT; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Carmen S; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Huntington CE; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Flavell L; Department of Discovery Sciences, Innovative Medicines, AstraZeneca, Mereside, Alderley Park, SK10 4TG, UK., Xu J; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Popovic B; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Brightling CE; Department of Infection, Immunity and Inflammation, Institute for Lung Health, Leicester LE3 9QP, UK; NIHR Respiratory Biomedical Research Unit, University Hospitals of Leicester, Leicester LE3 9QP, UK., Vaughan TJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Butler R; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Lowe DC; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Higazi DR; Department of Biopharmaceutical Development, Analytical Biotechnology, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Corkill DJ; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., May RD; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Sleeman MA; Department of Respiratory, Inflammation and Autoimmunity, MedImmune Ltd, Granta Park, Great Abington, CB21 6GH, UK., Mustelin T; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland 20878, USA.

المصدر: Nature communications [Nat Commun] 2015 Sep 14; Vol. 6, pp. 8327. Date of Electronic Publication: 2015 Sep 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Asthma/*immunology , Interleukin-33/*metabolism , Receptors, Cell Surface/*immunology , Receptors, Interleukin/*immunology, Animals ; Asthma/genetics ; Asthma/metabolism ; Humans ; Interleukin-1 Receptor-Like 1 Protein ; Interleukin-33/genetics ; Interleukin-33/immunology ; Male ; Mice ; Mice, Inbred BALB C ; Oxidation-Reduction ; Receptors, Cell Surface/genetics ; Receptors, Interleukin/genetics

المؤلفون: Vousden KA; Department of Antibody Discovery and Protein Engineering, MedImmune, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK., Clarke DL, Lowe DC

المصدر: Inflammation & allergy drug targets [Inflamm Allergy Drug Targets] 2013 Apr; Vol. 12 (2), pp. 99-108.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101266886 Publication Model: Print Cited Medium: Internet ISSN: 2212-4055 (Electronic) Linking ISSN: 18715281 NLM ISO Abbreviation: Inflamm Allergy Drug Targets Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Anti-Idiotypic/*chemistry , Antibodies, Anti-Idiotypic/*therapeutic use , Antibodies, Monoclonal/*chemistry , Antibodies, Monoclonal/*therapeutic use , Asthma/*drug therapy , Pulmonary Disease, Chronic Obstructive/*drug therapy, Animals ; Humans